Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Alfacalcidol 250nanogram capsules
0906040B0AAAAAA
|
Alfacalcidol | Alfacalcidol | Nutrition and Blood | 104,919 |
|
Alfacalcidol 500nanogram capsules
0906040B0AAAIAI
|
Alfacalcidol | Alfacalcidol | Nutrition and Blood | 56,270 |
|
Alfacalcidol 1microgram capsules
0906040B0AAABAB
|
Alfacalcidol | Alfacalcidol | Nutrition and Blood | 38,540 |
|
Alfacalcidol 2micrograms/ml oral drops sugar free
0906040B0AAAJAJ
|
Alfacalcidol | Alfacalcidol | Nutrition and Blood | 3,872 |
|
Alfacalcidol 1micrograms/0.5ml inj ampoules
0906040B0AAAFAF
|
Alfacalcidol | Alfacalcidol | Nutrition and Blood | 15 |
|
Alfacalcidol 2micrograms/1ml solution for injection ampoules
0906040B0AAAGAG
|
Alfacalcidol | Alfacalcidol | Nutrition and Blood | 2 |
|
Alfacalcidol 1micrograms/5ml oral liquid
0906040B0AAAMAM
|
Alfacalcidol | Alfacalcidol | Nutrition and Blood | 1 |
|
Alfacalcidol 1mg/5ml oral liquid
0906040B0AAAKAK
|
Alfacalcidol | Alfacalcidol | Nutrition and Blood | No data available |
|
Alfacalcidol 625nanograms/5ml oral liquid
0906040B0AAALAL
|
Alfacalcidol | Alfacalcidol | Nutrition and Blood | No data available |
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.